Navigation Links
More Dollars Don't Boost Lung Cancer Survival

5-year outcomes unchanged since 1970s, despite higher spending on care, study shows

TUESDAY, Oct 23 (HealthDay News) -- Although it can cost more than $1 million to give a lung cancer patient an added year of life, overall survival from the disease hasn't increased significantly, a new study finds.

On average, life-expectancy for Americans with lung cancer increased by less than one month between 1983 and 1997. At the same time, medical costs increased by more than $20,000 per patient, researchers reported in the Oct. 22 online edition of Cancer.

"We haven't made much progress in lung cancer survival, and what progress we have made has come at a significant cost," said Dr. Len Lichtenfeld, deputy chief medical officer at the American Cancer Society. He was not involved in the research.

"The concern is that as we move toward closer examination of survival of people with lung cancer and as our resources in this country become more strained, we are going to see more estimates about how much it costs to save a year of life," Lichtenfeld said.

Today, people diagnosed with lung cancer expect to get the full range of treatment, Lichtenfeld said. But as money becomes less available for health care, studies like this could impact on how health care providers make treatment decisions, he said.

"Right now, money isn't influencing our decisions," Lichtenfeld said. "But, when we look forward 20 years from now, we are going to make decisions about who we treat and how we treat them based on economic considerations," he said. "We are at risk in this country of moving in that direction."

Another expert is hopeful that type of system will never come to pass, however.

"This is America -- we don't ration health care," said Dr. Norman Edelman, chief medical officer at the American Lung Association, New York City.

In addition, Edelman is against pitting one disease against another. "Twenty-five percent of our health care dollars are spent on the last six months of life," he said. "And that's certainly not just lung cancer. Singling out lung cancer is not a useful approach."

According to Edelman, "The costs to treat lung cancer are not higher than the costs of anything else."

Lung cancer remains the leading cause of cancer death in the United States. This year 160,390 Americans will die from the disease.

In the study, a team led by Rebecca Woodward of the U.S. National Bureau of Economic Research drew on data from the National Cancer Institute's Surveillance, Epidemiology, and End Results database. They also looked at reimbursement data from Medicare Parts A and B.

The researchers tracked changes in both costs and outcomes for lung cancer patients from the early 1980s to the mid-1990s.

They found that an additional year of life for a patient with lung cancer cost an average of $403,142. The cost of each additional year of survival for people with local disease was $143,614. For people with metastatic lung cancer, each year of additional survival cost $1,190,322, Woodward's team found.

Each in the United States, more than $5 billion is spent on detecting, diagnosing and treating lung cancer. However, the one-year survival rate from the disease has increased only 5 percent from the late 1970s to 2002, the researchers noted -- between 1975 to 1979 the one-year survival rate for lung cancer patients was 37 percent and, in 2002, it was 42 percent, they said.

Over the same period, the five-year survival rate for those with lung cancer has remained about the same -- currently, it's only about 16 percent.

"The additional money spent on lung cancer treatment in the mid-1990s compared to in the early 1980s did not result in a favorable economic rate of return by conventional benchmarks," the researchers concluded.

To help reduce surging costs, more research is needed to develop better and more effective diagnostic tests and treatments, Edelman said.

"Clearly, we need a really good methodology for detection," he said. "We do need to figure much better ways to treat it," he added.

The most cost-effective way of bringing lung cancer costs under control is to prevent the disease in the first place, Edelman added, and that means "getting the government to spend more money to prevent smoking."

More information

For more on lung cancer, visit the American Lung Association.

SOURCES: Len Lichtenfeld, M.D., deputy chief medical officer, American Cancer Society, Atlanta; Norman Edelman, M.D., chief medical officer, American Lung Association, New York City; Oct. 22, 2007, online edition, Cancer

Copyright©2007 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. George Bush pledges 200 million dollars for AIDS relief
2. Azerbaijan Granted 5 million dollars in Fight Against Bird Flu
3. Flesh, blood and a few dollars more
4. Billions of Dollars Saved in U.S. By Polio Vaccination
5. 500 Million US Dollars to Fight Childhood Obesity
6. Zimbabwe Receives 15m Dollars of AIDS Drugs from US
7. Germany Pledges 5.4 Billion Dollars for AIDS Fund
8. World Bank Loans Kenya 80 Million Dollars to Boost War on AIDS
9. Half a Million Dollars Offered for GPs With Expertise in Anesthetics and Obstetrics
10. Heart disease correlation to periodontal disease
11. WBC linked with periodontitis
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... For the first time, Vitalalert ... Organizations, One Beat ” campaign. The partnership between the two groups began in 2014 ... MAP International’s cause. , MAP International was founded in 1954 and is an international ...
(Date:11/25/2015)... ... ... On November 25, 2015, officials of Narconon Arrowhead , the drug rehabilitation ... new cutting edge recovery program that has been 50 years in the making. ... with the purpose to free addicts from the symptoms and negative behaviors of addiction. ...
(Date:11/25/2015)... ... ... Smiles by Stevens is pleased to announce the addition of Botox® for ... aware of the benefits of Botox® in the treatment of moderate facial wrinkling, few ... and pain as a result of Jaw Tension, TMJ (temporo-mandibular joint) disorder, and Bruxism ...
(Date:11/25/2015)... ... November 25, 2015 , ... In an ongoing Clinical Study conducted by an ... IL, UV Angel is evaluating the efficacy of its product and its disinfection protocol. ... 30 beds) from May 2014 through October 2015 at a 360-bed, acute-care, academic medical ...
(Date:11/25/2015)... Spring, Md (PRWEB) , ... November 25, 2015 ... ... Pulmonary Hypertension Association (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible ... history of this disease. The Periwinkle Pioneers, nominated by the public, will receive ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... 2015 Kitov Pharma ceuticals ... a biopharmaceutical company focused on the development of therapeutic ... today announced the closing of its previously announced underwritten ... ), each representing 20 ordinary shares of the Company, ... ADSs and warrants were issued in a fixed combination ...
(Date:11/25/2015)...  Today AVACEN Medical announced the issue of United States patent No. ... ". This patent shields the company,s AVACEN 100 dry heat therapy medical device and specific methods ... Photo - ... ... ...
(Date:11/25/2015)... , Nov. 25, 2015 USP 800 ... drug preparations (e.g. pharmacists, pharmacy technicians, nurses, physicians, ... technicians). The chapter also covers all entities which ... pharmacies, hospitals, other healthcare institutions, patient treatment clinics, ... --> --> What is ...
Breaking Medicine Technology: